Cancer genetics of epigenetic genes.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Human Molecular Genetics

• Publication date

  2007-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDM021PMID 17613546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EPIGENETIC REGULATION OF CELLULAR MEMORY BY THE POLYCOMB AND TRITHORAX GROUP PROTEINS

  2008cited by this paper
• Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues

  2007cited by this paper
• Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study.

  2007cited by this paper
• Epigenetics provides a new generation of oncogenes and tumour-suppressor genes.

  2007influential reference
• Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers

  2007cited by this paper
• p300 is required for orderly G1/S transition in human cancer cells

  2007cited by this paper
• Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.

  2007cited by this paper
• Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.

  2006cited by this paper
• The necessity of a human epigenome project.

  2006cited by this paper
• Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

  2006cited by this paper
• Genetic variants in epigenetic genes and breast cancer risk.

  2006influential reference
• [Cancer epigenetics].

  2006cited by this paper
• The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3

  2006cited by this paper
• Oncology : an evidence-based approach

  2006cited by this paper
• DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas.

  2006cited by this paper
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006influential reference
• Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues.

  2006cited by this paper
• Enhanced SMYD3 expression is essential for the growth of breast cancer cells

  2006cited by this paper
• Histone lysine demethylases and their impact on epigenetics.

  2006cited by this paper
• EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.

  2006cited by this paper
• MLL/GAS7 fusion in a pediatric case of t(11;17)(q23;p13)-positive precursor B-cell acute lymphoblastic leukemia.

  2006influential reference
• The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36

  2006influential reference
• Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.

  2006cited by this paper
• Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer

  2006cited by this paper
• A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

  2006influential reference
• The cancer epigenome--components and functional correlates.

  2006cited by this paper
• The MLL recombinome of acute leukemias

  2006cited by this paper
• Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients

  2006influential reference
• Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.

  2006cited by this paper
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper
• Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement

  2006cited by this paper
• Breast tumor copy number aberration phenotypes and genomic instability

  2006cited by this paper
• SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23)

  2006influential reference
• The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

  2006influential reference
• Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band

  2006cited by this paper
• Regional copy number–independent deregulation of transcription in cancer

  2006cited by this paper
• Polycomb silencers control cell fate, development and cancer

  2006cited by this paper
• JmjC-domain-containing proteins and histone demethylation

  2006cited by this paper
• A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology

  2006cited by this paper
• The MLL partial tandem duplication in acute myeloid leukaemia

  2006cited by this paper
• Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.

  2006cited by this paper
• Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants

  2006influential reference
• Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer.

  2006cited by this paper
• Elevated mRNA levels of DNA methyltransferase‐1 as an independent prognostic factor in primary nonsmall cell lung cancer

  2006cited by this paper
• The Polycomb group protein EZH2 directly controls DNA methylation

  2006cited by this paper
• The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.

  2006influential reference
• JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.

  2006cited by this paper
• Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers

  2006cited by this paper
• Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer.

  2006cited by this paper
• A case of acute myelogenous leukemia with MLL-AF10 fusion caused by insertion of 5' MLL into 10p12, with concurrent 3' MLL deletion.

  2006cited by this paper
• Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues

  2006cited by this paper
• DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.

  2006cited by this paper
• Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.

  2005cited by this paper
• Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder

  2005cited by this paper
• Identification of a Chromosomal Breakpoint and Detection of a Novel Form of an MLL- AF17 Fusion Transcript in Acute Monocytic Leukemia with t(11;17)(q23;q21)

  2005cited by this paper
• Chromatin modifier enzymes, the histone code and cancer.

  2005influential reference
• Cancer epigenetics.

  2005cited by this paper
• Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas.

  2005cited by this paper
• Role of MBD2 in gene regulation and tumorigenesis.

  2005cited by this paper
• The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis.

  2005influential reference
• No Association between Polymorphisms in the Histone Deacetylase Genes and the Risk of Lung Cancer

  2005cited by this paper
• MLL is fused to EB1 (MAPRE1), which encodes a microtubule‐associated protein, in a patient with acute lymphoblastic leukemia

  2005influential reference
• Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.

  2005cited by this paper
• Secondary acute myeloid leukemia with translocation (4;11) and MLL/AF4 rearrangement in a 15-year-old boy treated for common acute lymphoblastic leukemia 11 years earlier

  2005cited by this paper
• Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases.

  2005cited by this paper
• Mechanisms predisposing to childhood overgrowth and cancer.

  2005cited by this paper
• Partial tandem duplication of MLL gene in acute myeloid leukemia with translocation (11;17)(q23;q12–21)

  2005cited by this paper
• Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations.

  2005cited by this paper
• Towards the Human Cancer Epigenome: A First Draft of Histone Modifications

  2005cited by this paper
• Increased Protein Stability Causes DNA Methyltransferase 1 Dysregulation in Breast Cancer*

  2005cited by this paper
• Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer.

  2005cited by this paper
• Mll fusions generated by Cre‐loxP‐mediated de novo translocations can induce lineage reassignment in tumorigenesis

  2005cited by this paper
• Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.

  2005cited by this paper
• Mutations and deletions of the CBP gene in human lung cancer.

  2005cited by this paper
• DNA methyltransferase 1 expression and promoter methylation of E‐cadherin in mucoepidermoid carcinoma

  2005cited by this paper
• Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk

  2005cited by this paper
• Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

  2005influential reference
• Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes.

  2005cited by this paper
• Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases.

  2005cited by this paper
• High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

  2005cited by this paper
• The diverse functions of histone lysine methylation

  2005cited by this paper
• Acute myelocytic leukemia with t(11;17)(q23;q12-q21) involves a fusion of MLL and AF17.

  2005cited by this paper
• Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells.

  2005cited by this paper
• The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women

  2005cited by this paper
• Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

  2005cited by this paper
• Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

  2005cited by this paper
• Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors.

  2005cited by this paper
• Methyl-CpG Binding Domain 1 Gene Polymorphisms and Risk of Primary Lung Cancer

  2005cited by this paper
• [Application of reverse transcription-multiplex nested PCR to detect MLL rearrangement in AML-M4/M5].

  2005influential reference
• DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.

  2005cited by this paper
• Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal status

  2005cited by this paper
• Global histone modification patterns predict risk of prostate cancer recurrence

  2005cited by this paper
• Association of NCOA3 Polymorphisms with Breast Cancer Risk

  2005cited by this paper
• Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China.

  2005cited by this paper
• The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells.

  2005cited by this paper
• Risk of tumorigenesis in overgrowth syndromes: A comprehensive review

  2005cited by this paper
• Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma

  2005cited by this paper
• A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers

  2005cited by this paper
• No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer

  2004cited by this paper
• Gene Expression Signatures Identify Rhabdomyosarcoma Subtypes and Detect a Novel t(2;2)(q35;p23) Translocation Fusing PAX3 to NCOA1

  2004cited by this paper

• Unveiling DNA methylation: early diagnosis, risk assessment, and therapy for endometrial cancer

  2025cites this paper
• Daidzein reprograms EP300/CREBBP-deficient immune evasion via targeting the PPARγ-ANGPT4/Tie2 axis in hypopharyngeal squamous cell carcinoma.

  2025cites this paper
• Epigenetic regulation of MMP-11 and -16 expression in human prostate cancer: the role of KDM6A.

  2025cites this paper
• Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma and its Clinical Implications in Systemic Chemotherapy

  2025cites this paper
• Protein arginine methyltransferase 7 regulates the cell cycle and promotes the progression of prostate cancer

  2025cites this paper
• Alvaradoin E: an update of its anticancer potential and mechanisms of action

  2024cites this paper
• In-silico and biochemical analysis of ethyl acetate fraction of Olax subscorpioidea leaf on DMBA-induced cell proliferation in female rats

  2024cites this paper
• Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: Mechanisms insights and efficiencies.

  2024cites this paper
• Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy

  2023cites this paper
• Characterizing crosstalk in epigenetic signaling to understand disease physiology.

  2023cites this paper
• Epigenetic Modulations for Prevention of Infectious Diseases in Shrimp Aquaculture

  2023cites this paper
• Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

  2023cites this paper
• High levels of histone H3 K27 acetylation and tri-methylation are associated with shorter survival in oral squamous cell carcinoma patients

  2023cites this paper
• The Interplay between T Cells and Cancer: The Basis of Immunotherapy

  2023cites this paper
• Epigenetic reprogramming in pancreatic premalignancy and clinical implications

  2023cites this paper
• Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer

  2022cites this paper
• mRNA expression and epigenetic-based role of chromodomain helicase DNA-binding 5 in hepatocellular carcinoma

  2022cites this paper
• Epigenetic alterations fuel brain metastasis via regulating inflammatory cascade.

  2022cites this paper
• Effect of Thymidine Phosphorylase Gene Demethylation on Sensitivity to 5-Fluorouracil in Colorectal Cancer Cells

  2022cites this paper
• miRNAs Copy Number Variations Repertoire as Hallmark Indicator of Cancer Species Predisposition

  2021cites this paper
• Tumor Biology and Natural History

  2021cites this paper
• Epigenetic effects of pharmacologic ascorbate

  2021cites this paper
• Gasdermin E-mediated programmed cell death: An unpaved path to tumor suppression

  2021cites this paper
• Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression

  2021cites this paper
• Targeting DNA methyltransferases in Non-small-cell lung cancer.

  2021cites this paper
• A Chemo-Genomic Approach Identifies Diverse Epigenetic Therapeutic Vulnerabilities in MYCN-Amplified Neuroblastoma

  2021cites this paper
• A STUDY ON MOLECULAR TARGETED APPROACHES TO CANCER THERAPY AND THE ROLE OF CHALCONES IN CHEMOPREVENTION

  2021cites this paper
• Epigenetics and Genetic Changes in CHD5 and Risk of Hepatocellular Carcinoma

  2020cites this paper
• Approaching Complex Diseases: Network-Based Pharmacology and Systems Approach in Bio-Medicine

  2020cites this paper
• Epigenetic Control Using Small Molecules in Cancer

  2020cites this paper
• Regulation of alternative polyadenylation in the yeast Saccharomyces cerevisiae by histone H3K4 and H3K36 methyltransferases

  2020cites this paper
• Overexpression of MECP2 attenuates cigarette smoke extracts induced lung epithelial cell injury by promoting CYP1B1 methylation.

  2020cites this paper
• Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer.

  2020cites this paper
• Curcumin effect on cancer cells' multidrug resistance: An update

  2020cites this paper
• Investigating the structural features of chromodomain proteins in the human genome and predictive impacts of their mutations in cancers.

  2019cites this paper
• CMAR_A_201610 6379..6396

  2019cites this paper
• DNMT3a promotes proliferation by activating the STAT3 signaling pathway and depressing apoptosis in pancreatic cancer

  2019cites this paper
• Epigenomics of Diabetes Mellitus

  2019cites this paper
• Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents.

  2019cites this paper
• The Association between the Methyltransferase DNMT3A and Cancer

  2019cites this paper
• Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

  2019cites this paper
• Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications

  2019cites this paper
• Epigenetic-Based Cancer Therapy

  2019cites this paper
• Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: a genotype-phenotype study.

  2019cites this paper
• Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5

  2019cites this paper
• Study of KMT2B (MLL2) gene expression changes in patients with breast cancer

  2019cites this paper
• Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment

  2019cites this paper
• Epigenetic Events in Lung Cancer: Chromatin Remodeling and DNA Methylation

  2018cites this paper
• An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy

  2018cites this paper
• Epimutation and Cancer: Carcinogenesis Viewed as Error-Prone Inheritance of Epigenetic Information

  2018cites this paper
• CpG Islands in Cancer: Heads, Tails, and Sides.

  2018cites this paper
• Serum glycine dehydrogenase is associated with increased risk of lung cancer and promotes malignant transformation by regulating DNA methyltransferases expression.

  2018cites this paper
• Clinical relevance of DNA methyltransferase 3a (dnmt3a) mutation in patients with acute myeloid leukemia

  2018cites this paper
• DNA methylation patterns as molecular biomarkers: an overview in colorectal cancer

  2018cites this paper
• Rpb9-deficient cells are defective in DNA damage response and require histone H3 acetylation for survival

  2018cites this paper
• The Effect of Dietary Constituents on Regulation of Epigenetic Changes in Cancer

  2017cites this paper
• The Epigenetic Theory of Carcinogenesis: p53 as the Guardian of The Epigenome

  2017cites this paper
• Review of cancer from perspective of molecular

  2017cites this paper
• Epigenetic regulation of RET receptor tyrosine kinase and non-coding RNAs in MTC.

  2017cites this paper
• Identification and characterisation of novel cancer testis antigens in human cancer cells

  2017cites this paper
• SET oncoprotein accumulation regulates transcription through DNA demethylation and histone hypoacetylation

  2017cites this paper
• Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents

  2017cites this paper
• Epigenetic Basis of Human Cancer

  2017cites this paper
• Immunohistochemical evaluation of Klotho and DNA methyltransferase 3a in oral squamous cell carcinomas

  2017cites this paper
• The Role of Epigenetics

  2017cites this paper
• Human papillomaviruses in epigenetic regulations.

  2017cites this paper
• Enzymatic characterization of protein lysine methyltransferases

  2017cites this paper
• The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent

  2016cites this paper
• A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma

  2016cites this paper
• Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents

  2016cites this paper
• Functional Analysis of Histone Deacetylase 11 (HDAC11).

  2016cites this paper
• 5-Azacytidine regulates matrix metalloproteinase-9 expression, and the migration and invasion of human fibrosarcoma HT1080 cells via PI3-kinase and ERK1/2 pathways.

  2016cites this paper
• Characterization and Use of Folate Receptor Isoforms for Targeting of Epithelial and Myeloid Cells

  2016cites this paper
• Histone Posttranslational Modifications and Chromatin Remodelers in Prostate Cancer

  2016cites this paper
• Epigenetic Impact of Bioactive Dietary Compounds in Cancer Chemoprevention

  2016cites this paper
• Histone Deacetylases

  2016cites this paper
• Structure and dynamics of H. pylori 98-10 C5-cytosine specific DNA methyltransferase in complex with S-adenosyl-l-methionine and DNA.

  2016cites this paper
• Epigenetic Determinants of Cancer.

  2016influential citation
• Epigenetic Alterations in Endocrine-Dependent Cancers: Implications of Endocrine Dysfunctions

  2016cites this paper
• Integrating Epigenomics into the Understanding of Biomedical Insight

  2016cites this paper
• Polymorphisms of the DNA Methyltransferase 1 Gene Predict Survival of Gastric Cancer Patients Receiving Tumorectomy

  2016cites this paper
• DNA methylation analysis in constitutional disorders: Clinical implications of the epigenome

  2016cites this paper
• A non-coding RNA network influenced by genetic polymorphism controls E-cadherin expression in human cancers

  2016cites this paper
• Natural Agents Used in Chemoprevention of Aerodigestive and GI Cancers

  2016cites this paper
• Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells

  2016cites this paper
• Genetic variation in one-carbon metabolism in relation to genome-wide DNA methylation in breast tissue from heathy women.

  2016cites this paper
• miRNA regulation of Sirtuin-1 expression in human astrocytoma.

  2016cites this paper
• Epigenetic Regulation by Dietary Phytochemicals in Photocarcinogenesis

  2015cites this paper
• Epigenetic activities of flavonoids in the prevention and treatment of cancer

  2015influential citation
• Targeted Therapies for Gastric Cancer

  2015cites this paper
• DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status

  2015cites this paper
• Cancer Epigenetics

  2015cites this paper
• EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

  2015cites this paper
• Cigarette smoke induces proteasomal-mediated degradation of DNA methyltransferases and methyl CpG-/CpG domain-binding proteins in embryonic orofacial cells.

  2015cites this paper
• Integrated genomic analyses identify KDM1A's role in cell proliferation via modulating E2F signaling activity and associate with poor clinical outcome in oral cancer.

  2015cites this paper
• SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3

  2015cites this paper
• Cancer epigenetics: an introduction.

  2015cites this paper
• Nonrandom chromosome abnormalities in cancer: An overview

  2015cites this paper
• Clinical Pharmacology and Toxicology of Mustard Compounds

  2015cites this paper
• Anticancer Effects and uses of Melatonin A Review

  2015cites this paper